Latest Financial Guidance News

Page 4 of 23
Telix Pharmaceuticals has announced FDA acceptance of its resubmitted NDA for TLX101-Px (Pixclara®), a PET imaging agent for glioma, setting a PDUFA goal date of September 11, 2026. The agent addresses a significant unmet need in distinguishing recurrent glioma from treatment effects.
Ada Torres
Ada Torres
10 Apr 2026
PlaySide Studios Limited (ASX: PLY) has announced that its upcoming game MOUSE: P.I. For Hire has exceeded 1.5 million wishlists, surpassing previous guidance, ahead of its global digital launch on 16 April 2026. The company expects FY26 revenue to exceed FY25 with reduced operating costs.
Sophie Babbage
Sophie Babbage
9 Apr 2026
Following ASIC's final inquiry report, ASX unveils a comprehensive transformation plan focusing on governance, leadership, and risk management, alongside a significant capital charge.
Claire Turing
Claire Turing
2 Apr 2026
Harvest Technology Group is sharpening its focus on defence markets following an independent review that validates its Nodestream platform’s relevance. The company has initiated third-party validation and made significant leadership changes, including the CEO’s departure.
Sophie Babbage
Sophie Babbage
2 Apr 2026
Acrow Limited has reported record new hire contracts and a robust sales pipeline, confirming FY26 guidance and issuing optimistic initial guidance for FY27 revenue and earnings.
Victor Sage
Victor Sage
1 Apr 2026
Tyro Payments welcomes the Reserve Bank of Australia's reforms to merchant card payment costs, highlighting opportunities from increased transparency and competition. The changes, effective from October 2026, align with Tyro’s transparent pricing model and do not affect its near-term guidance.
Claire Turing
Claire Turing
31 Mar 2026
Webjet Group announces the resignation of CEO Katrina Barry, who led the company through a major demerger and strategic overhaul. The company reaffirms its FY26 EBITDA guidance despite ongoing leadership changes.
Victor Sage
Victor Sage
30 Mar 2026
BCAL Diagnostics is expanding access to its Avantect pancreatic and ovarian cancer blood tests across Australia through partnerships with major pathology providers. This move marks a significant step in making early cancer detection more widely available.
Ada Torres
Ada Torres
26 Mar 2026
Sims Lifecycle Services (SLS) has emerged as a powerhouse within Sims Group, driving nearly 40% of group earnings through strategic hyperscaler partnerships and capitalising on structural shifts in the memory market.
Sophie Babbage
Sophie Babbage
26 Mar 2026
Etherstack plc has secured a significant revenue uplift from a scope change in its primary UK government project, adding £1.53 million to its future earnings forecast for FY27.
Sophie Babbage
Sophie Babbage
24 Mar 2026
Sims Limited projects a robust FY26 underlying EBIT between $350 million and $400 million, buoyed by strong non-ferrous metal prices and resilient memory chip demand despite geopolitical and market headwinds.
Maxwell Dee
Maxwell Dee
18 Mar 2026
Verbrec Limited has promoted Mark Read from CEO to Managing Director, extending his notice period to ensure leadership continuity as the company builds on its recent turnaround.
Victor Sage
Victor Sage
16 Mar 2026